Shenyang Xingqi Pharmaceutical Co Ltd Total Liabilities

Latest as of September 2025: CN¥562.18 Million CNY ≈ $82.26 Million USD

Shenyang Xingqi Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Shenyang Xingqi Pharmaceutical Co Ltd (300573) has total liabilities worth CN¥562.18 Million CNY (≈ $82.26 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Shenyang Xingqi Pharmaceutical Co Ltd (300573) liquidity interval to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Shenyang Xingqi Pharmaceutical Co Ltd (2011–2024)

Total liabilities of Shenyang Xingqi Pharmaceutical Co Ltd from 2011 to 2024. This chart illustrates how Shenyang Xingqi Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Shenyang Xingqi Pharmaceutical Co Ltd (300573) long-term investment share to see how much of total assets are deployed in long-term investments.

Shenyang Xingqi Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shenyang Xingqi Pharmaceutical Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Edelweiss Financial Services Limited
NSE:EDELWEISS
India Rs377.98 Billion
STAAR Surgical Company
NASDAQ:STAA
USA $109.81 Million
Hubei Jianghan New Materials Co. Ltd. A
SHG:603281
China CN¥351.43 Million
HuBei SanFeng Intelligent Conveying Equipment Co Ltd
SHE:300276
China CN¥2.80 Billion
Nabors Industries Ltd
F:NBI1
Germany €2.94 Billion
Jinhui Liquor Co Ltd
SHG:603919
China CN¥1.55 Billion
Landis+Gyr Group AG
SW:LAND
Switzerland CHF1.20 Billion
Klöckner & Co SE
XETRA:KCO
Germany €2.06 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down Shenyang Xingqi Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Shenyang Xingqi Pharmaceutical Co Ltd balance sheet assets.

Liquidity & Leverage Metrics

Shenyang Xingqi Pharmaceutical Co Ltd Total Liabilities Ratios Explained

Shenyang Xingqi Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.90 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.30 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.23 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shenyang Xingqi Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shenyang Xingqi Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual total liabilities of Shenyang Xingqi Pharmaceutical Co Ltd from 2011 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥534.48 Million
≈ $78.21 Million
+60.06%
2023-12-31 CN¥333.92 Million
≈ $48.86 Million
+44.79%
2022-12-31 CN¥230.63 Million
≈ $33.75 Million
-32.63%
2021-12-31 CN¥342.35 Million
≈ $50.10 Million
+26.03%
2020-12-31 CN¥271.64 Million
≈ $39.75 Million
-2.10%
2019-12-31 CN¥277.46 Million
≈ $40.60 Million
+80.30%
2018-12-31 CN¥153.89 Million
≈ $22.52 Million
+25.02%
2017-12-31 CN¥123.09 Million
≈ $18.01 Million
-38.60%
2016-12-31 CN¥200.47 Million
≈ $29.33 Million
-23.24%
2015-12-31 CN¥261.15 Million
≈ $38.21 Million
-13.84%
2014-12-31 CN¥303.09 Million
≈ $44.35 Million
+31.55%
2013-12-31 CN¥230.41 Million
≈ $33.72 Million
+80.97%
2012-12-31 CN¥127.32 Million
≈ $18.63 Million
+509.68%
2011-12-31 CN¥20.88 Million
≈ $3.06 Million
--

About Shenyang Xingqi Pharmaceutical Co Ltd

SHE:300573 China Medical Instruments & Supplies
Market Cap
$1.25 Billion
CN¥8.55 Billion CNY
Market Cap Rank
#7686 Global
#1635 in China
Share Price
CN¥34.68
Change (1 day)
+2.73%
52-Week Range
CN¥32.86 - CN¥82.72
All Time High
CN¥204.82
About

Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic medications in the People's Republic of China. The company provides myopia prevention and control medications, nutrition and corneal repair drugs, ophthalmic anti-inflammatory/anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs… Read more